Glial-Mediated Inflammation Underlying Parkinsonism
The interest in studying neuroimmune interactions is increasing in the scientific community, and for many researchers, immunity is becoming a crucial factor in the understanding of the physiology of the normal brain as well as the biology underlying neurodegenerative diseases. Mounting data over the...
Saved in:
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2013-01-01
|
| Series: | Scientifica |
| Online Access: | http://dx.doi.org/10.1155/2013/357805 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849469520916250624 |
|---|---|
| author | Carlos Barcia |
| author_facet | Carlos Barcia |
| author_sort | Carlos Barcia |
| collection | DOAJ |
| description | The interest in studying neuroimmune interactions is increasing in the scientific community, and for many researchers, immunity is becoming a crucial factor in the understanding of the physiology of the normal brain as well as the biology underlying neurodegenerative diseases. Mounting data over the last two decades point toward immune and inflammatory alterations as important mediators of the progressive dopaminergic degeneration in Parkinson’s disease. The purpose of this review is to address, under a historical perspective, as well as in the light of recent reports, the glial-mediated inflammatory and immune responses that occur in Parkinsonism. In line with this, this review also evaluates and highlights available anti-inflammatory drugs and putative targets for Parkinson’s disease therapy for the near future. |
| format | Article |
| id | doaj-art-fd41788a22a342a0baf18b6b2ff52097 |
| institution | Kabale University |
| issn | 2090-908X |
| language | English |
| publishDate | 2013-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Scientifica |
| spelling | doaj-art-fd41788a22a342a0baf18b6b2ff520972025-08-20T03:25:26ZengWileyScientifica2090-908X2013-01-01201310.1155/2013/357805357805Glial-Mediated Inflammation Underlying ParkinsonismCarlos Barcia0Department of Biochemistry and Molecular Biology, Institute of Neuroscience & School of Medicine, Universitat Autònoma de Barcelona, Campus de Bellaterra, Cerdanyola del Vallès, 08193 Barcelona, SpainThe interest in studying neuroimmune interactions is increasing in the scientific community, and for many researchers, immunity is becoming a crucial factor in the understanding of the physiology of the normal brain as well as the biology underlying neurodegenerative diseases. Mounting data over the last two decades point toward immune and inflammatory alterations as important mediators of the progressive dopaminergic degeneration in Parkinson’s disease. The purpose of this review is to address, under a historical perspective, as well as in the light of recent reports, the glial-mediated inflammatory and immune responses that occur in Parkinsonism. In line with this, this review also evaluates and highlights available anti-inflammatory drugs and putative targets for Parkinson’s disease therapy for the near future.http://dx.doi.org/10.1155/2013/357805 |
| spellingShingle | Carlos Barcia Glial-Mediated Inflammation Underlying Parkinsonism Scientifica |
| title | Glial-Mediated Inflammation Underlying Parkinsonism |
| title_full | Glial-Mediated Inflammation Underlying Parkinsonism |
| title_fullStr | Glial-Mediated Inflammation Underlying Parkinsonism |
| title_full_unstemmed | Glial-Mediated Inflammation Underlying Parkinsonism |
| title_short | Glial-Mediated Inflammation Underlying Parkinsonism |
| title_sort | glial mediated inflammation underlying parkinsonism |
| url | http://dx.doi.org/10.1155/2013/357805 |
| work_keys_str_mv | AT carlosbarcia glialmediatedinflammationunderlyingparkinsonism |